| Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations J Guarnerio, M Bezzi, JC Jeong, SV Paffenholz, K Berry, MM Naldini, ... Cell 165 (2), 289-302, 2016 | 720 | 2016 |
| Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function A Papa, L Wan, M Bonora, L Salmena, MS Song, RM Hobbs, A Lunardi, ... Cell 157 (3), 595-610, 2014 | 307 | 2014 |
| Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer S Wei, S Kozono, L Kats, M Nechama, W Li, J Guarnerio, M Luo, MH You, ... Nature medicine 21 (5), 457-466, 2015 | 263 | 2015 |
| PHD3 loss in cancer enables metabolic reliance on fatty acid oxidation via deactivation of ACC2 NJ German, H Yoon, RZ Yusuf, JP Murphy, LWS Finley, G Laurent, ... Molecular cell 63 (6), 1006-1020, 2016 | 150 | 2016 |
| Intragenic antagonistic roles of protein and circRNA in tumorigenesis J Guarnerio, Y Zhang, G Cheloni, R Panella, J Mae Katon, M Simpson, ... Cell research 29 (8), 628-640, 2019 | 132 | 2019 |
| Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy SL Shiao, KM Kershaw, JJ Limon, S You, J Yoon, EY Ko, J Guarnerio, ... Cancer cell 39 (9), 1202-1213. e6, 2021 | 131 | 2021 |
| Role of LRF/Pokemon in lineage fate decisions A Lunardi, J Guarnerio, G Wang, T Maeda, PP Pandolfi Blood, The Journal of the American Society of Hematology 121 (15), 2845-2853, 2013 | 71 | 2013 |
| A circular twist on microRNA regulation M Bezzi, J Guarnerio, PP Pandolfi Cell Research 27 (12), 1401-1402, 2017 | 50 | 2017 |
| Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis A Lunardi, S Varmeh, M Chen, R Taulli, J Guarnerio, U Ala, N Seitzer, ... Cancer discovery 5 (5), 550-563, 2015 | 45 | 2015 |
| HIF factors cooperate with PML‐RAR α to promote acute promyelocytic leukemia progression and relapse N Coltella, S Percio, R Valsecchi, R Cuttano, J Guarnerio, M Ponzoni, ... EMBO molecular medicine 6 (5), 640-650, 2014 | 43 | 2014 |
| Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy V Mugoni, R Panella, G Cheloni, M Chen, O Pozdnyakova, D Stroopinsky, ... Cell research 29 (6), 446-459, 2019 | 40 | 2019 |
| Bone marrow endosteal mesenchymal progenitors depend on HIF factors for maintenance and regulation of hematopoiesis J Guarnerio, N Coltella, U Ala, G Tonon, PP Pandolfi, R Bernardi Stem cell reports 2 (6), 794-809, 2014 | 34 | 2014 |
| Synthetic CD4+ T Cell–Targeted Antigen-Presenting Cells Elicit Protective Antitumor Responses S Caserta, P Alessi, J Guarnerio, V Basso, A Mondino Cancer research 68 (8), 3010-3018, 2008 | 34 | 2008 |
| A non-cell-autonomous role for Pml in the maintenance of leukemia from the niche J Guarnerio, LM Mendez, N Asada, AV Menon, J Fung, K Berry, ... Nature communications 9 (1), 66, 2018 | 31 | 2018 |
| A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells J Guarnerio, L Riccardi, R Taulli, T Maeda, G Wang, RM Hobbs, MS Song, ... Cancer discovery 5 (4), 396-409, 2015 | 26 | 2015 |
| Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors F Nikolos, K Hayashi, XP Hoi, ME Alonzo, Q Mo, A Kasabyan, H Furuya, ... Nature Communications 13 (1), 1487, 2022 | 21 | 2022 |
| Single-cell RNA-seq of a soft-tissue sarcoma model reveals the critical role of tumor-expressed MIF in shaping macrophage heterogeneity FHG Tessaro, EY Ko, M De Simone, R Piras, MT Broz, HS Goodridge, ... Cell reports 39 (12), 2022 | 18 | 2022 |
| circCsnk1g3-and circAnkib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment R Piras, EY Ko, C Barrett, M De Simone, X Lin, MT Broz, FHG Tessaro, ... Nature Communications 13 (1), 7243, 2022 | 8 | 2022 |
| CircFISH: a novel method for the simultaneous imaging of linear and circular RNAs A Koppula, A Abdelgawad, J Guarnerio, M Batish, V Parashar Cancers 14 (2), 428, 2022 | 8 | 2022 |
| Antigen-Experienced CD4+ T Cells Limit Naïve T-Cell Priming in Response to Therapeutic Vaccination In vivo C Schiering, J Guarnerio, V Basso, L Muzio, A Mondino Cancer research 70 (15), 6161-6170, 2010 | 8 | 2010 |
